Senior Director, HIV Treatment Marketing, ISL-LEN HCP Promotions at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Strong leadership skills with ability to set a vision, manage change, and drive performance in a fast-moving, challenging, and dynamic commercial environment
High performing HCP marketer with ability to set a vision and provide direction across diverse internal and external stakeholders
Strategic thinker with innovation to develop marketing solutions to a wide range of complex problems consistent with organization objectives

Responsibilities

Oversee the development and implementation of strategic and tactical promotional plans for the HIV Treatment long acting market and ISL-LEN brand
Develop the ISL-LEN launch strategy and Plan of Action (POA) for field sales teams; coordinate with Commercial Learning and Development (CL&D) to provide guidance to implement
Distill market research findings into insights that support the strategy, positioning, messaging, and POA; coordinate with market insights team to set future direction for insight generation
Cultivate relationships with thought leaders, key customers, and professional organizations
Partner cross-functionally with Legal, Medical, Clinical, Regulatory, Public Affairs, and other functions, leading cross-functional projects as needed; ensure successful collaboration with Alliance partner and field leaders
Work with commercial operations to establish and optimize appropriate procedures, systems, metrics, and infrastructures
Collaborate with other local and global marketing leads as well as sales leads to ensure coordinated approach with respect to product promotions across the liver portfolio
Oversee relevant agency relationships and performance; manage budget oversight and key agency partnerships
Assist with forecasting and budget decisions
Lead the promotions team to develop and execute all promotional materials (both personal and non-personal)
Lead, in partnership with CL&D, the training for ISL-LEN with marketing and sales teams
Lead a cross-functional team to monitor and understand the evolving landscape of long acting treatments in HIV; provide recommendations for resource allocation (i.e., marketing mix) to adjust accordingly

Skills

Marketing Strategy

HCP Promotions

HIV Treatment

Long Acting Market

Budget Management

Agency Partnerships

Leadership

Change Management

Commercial Strategy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free